Hold Healthcare Global Enterprises, target Rs 320: Edelweiss
Hold Healthcare Global Enterprises Ltd. at a price target of Rs 320.0 .

Investment rationale by Edelweiss
Healthcare Global’s (HCG) Q4FY18 performance was in-line, with top-line growing 22% and EBITDA up 7% YoY. During the quarter, company closed the Kanpur centre, which it had commissioned in Q4FY17. Management estimated that payback and eventual growth would be slower than expected, as most patients came from government schemes. This was the third exit this fiscal, after Delhi in Q2FY18 and Trichy in Q3FY18, which were mainly due to issues with the partner. We liked HCG, being a singular bet on the promise of oncology tertiary care. However, lure of the therapy has attracted fierce competition from private and public players alike. Additionally, introduction of more government subsidy schemes could aggravate margin pressure. We believe the stock is fairly valued at current valuations. Maintain ‘HOLD’ with a TP of INR320.
Download ET Markets APP